Herombopag
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Herombopag for Chemotherapy-induced Thrombocytopenia (NCT05236582) | Institute of Hematology & Blood Diseases Hospital, China | 2022-03-14 |
Track Herombopag automatically
Every clearance here is in the API, with alerts when new ones post.